Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Esophageal cancer is the fourth leading cause of
cancer-associated
fatalities and the fourth most commonly diagnosed cancer. In addition to environmental risk factors, genetic factors may have a significant role in esophageal cancer carcinogenesis. A hospital-based case-control study was conducted to evaluate the genetic effects of functional single-nucleotide polymorphisms in the interleukin-18 (
IL-18
), IL-18 receptor 1 protein (
IL-18R1
),
IL-18 receptor accessory protein
(
IL-18RAP
) and
IL-28B
on the development of esophageal cancer. In total, 380 esophageal squamous cell carcinoma (ESCC) cases and 380 controls were recruited for the present study. The
IL-18
rs360719 A>G,
IL-18R1
rs13015714 G>T,
IL-18RAP
rs917997 C>T and
IL-28B
rs8099917 T>G genotypes were determined. No association was observed between the
IL-18R1
rs13015714 G>T,
IL-18RAP
rs917997 C>T and
IL-28B
rs8099917 T>G polymorphisms and the risk of ESCC. However, in stratification analyses, a significantly decreased risk of ESCC associated with the
IL-18R1
rs13015714 G>T polymorphism and a significantly increased risk of ESCC associated with the
IL-18RAP
rs917997 C>T polymorphism was evident among male patients and patients who smoked or consumed alcohol. These findings highlighted that functional polymorphisms
IL-18R1
rs13015714 G>T and
IL-18RAP
rs917997 C>T may contribute to ESCC susceptibility among these subgroups. However, the present results were obtained with a limited sample size and further epidemiological studies are warranted to clarify the role of
IL-18R1
and
IL-18RAP
variants in the development of ESCC.
...
PMID:Association of the interleukin-18 receptor 1 and interleukin-18 receptor accessory protein polymorphisms with the risk of esophageal cancer. 2689 44